Her-Shyong Shiah, MD

Hematology and Oncology

SPECIALTY/PRACTICE AREAS：
• Solid tumors
• Hematological maliganacy, e.g., Lymphoma, CML, etc.
• Clinical trials: Phase 0, Phase I, Phase II and Phase III, Phase IV
• Anemia
• Genetic consueling
LANGUAGES SPOKEN：
• English
• Chinese

 

PROFESSIONAL EDUCATION：

• Chung Shan Medical University, MD.

 

ADMINSTRATIVE APPOINTMENTS：

• Assistant Investigator & Attending Physician, National Institute of Cancer Research, National Health Research Institutes (2001.01-2012.10)
• Joint–Appointment Attending Physician, Hemato-oncology, National Cheng Kung University Hospital (2007.08-2012.10)
• Joint–Appointment Attending Physician, Hemato-oncology, Tri-Service General Hospital (2006.01-2007.12)
• Joint–Appointment Attending Physician, Hemato-oncology, Taiperi Veterans General Hospital (2004.08-2007.12)

 

PUBLICATIONS：

• Kuo CC, Liu TW, Chen LT, Shiah HS, Wu CM, Cheng YT, Pan WY, Liu JF, Chen KL, Yang YN, Chen SN, Chang JY. Combination of Arsenic Trioxide and BCNU Synergistically Triggers Redox–mediated Autophagic Cell Death in Human Solid Tumors. Free Radical Biology & Medicine. 2011 Dec 15;51(12):2195-209.（2010 SCI Impact factor: 5.707; Ranking: 16th of 116 in Endocrinology & Metablosim）
• Teng CF, Wu HC, Tsai HW, Shiah HS, Huang W, Su IJ. Novel Feedback Inhibition of Surface Antigen Synthesis by mTOR Signal and Its Implication for Hepatitis B Virus Tumorigenesis and Therapy. Hepatology. 2011 Oct;54(4):1199-1207.（2010 SCI Impact factor: 10.855; Ranking: 2th of 71 in Gastroenterology and Hepatolgoy）